Advertisement
YOU ARE HERE: LAT HomeCollectionsOncor Inc
IN THE NEWS

Oncor Inc

FEATURED ARTICLES
BUSINESS
January 1, 1998 | Bloomberg News
Oncor Inc. said it won Food and Drug Administration approval to sell its test to help breast cancer patients find out their chances of having a recurrence. The company's Inform test is the first that analyzes genetic material to predict cancer recurrence, the company said. About 40,000 women each year are at risk for recurring breast cancer, the company said. The FDA approval comes two years after an FDA advisory panel rejected the test, saying it needed further study.
ARTICLES BY DATE
BUSINESS
January 1, 1998 | Bloomberg News
Oncor Inc. said it won Food and Drug Administration approval to sell its test to help breast cancer patients find out their chances of having a recurrence. The company's Inform test is the first that analyzes genetic material to predict cancer recurrence, the company said. About 40,000 women each year are at risk for recurring breast cancer, the company said. The FDA approval comes two years after an FDA advisory panel rejected the test, saying it needed further study.
Advertisement
NEWS
December 1, 1995 | Associated Press
Government scientists Thursday rejected the first genetic test kit designed to predict which breast cancer patients could relapse after surgery and thus need tougher treatment. The test detects a gene believed to spur cancer cell growth. Several hospitals already check Americans with small, early tumors for the gene in deciding how aggressively to treat them. But those tests are experimental, performed with little government oversight, and their accuracy differs from lab to lab, said Dr.
Los Angeles Times Articles
|